|
1
|
T. Rowe Price Investment Management
Baltimore,
Maryland
|
$1.13B
|
-$84.9M
|
-1,364,124
|
-7%
|
|
|
2
|
|
$1.04B
|
+$54.1M
|
+869,376
|
+6%
|
|
|
3
|
Fidelity Investments
Boston,
Massachusetts
|
$814M
|
-$17.7M
|
-283,895
|
-2%
|
|
|
4
|
Vanguard Group
Malvern,
Pennsylvania
|
$766M
|
+$11.9M
|
+191,336
|
+2%
|
|
|
5
|
Wellington Management Group
Boston,
Massachusetts
|
$504M
|
+$32.9M
|
+528,502
|
+7%
|
|
|
6
|
State Street
Boston,
Massachusetts
|
$370M
|
+$12.9M
|
+207,961
|
+4%
|
|
|
7
|
Deep Track Capital
Greenwich,
Connecticut
|
$212M
|
-$59.9M
|
-963,002
|
-22%
|
|
|
8
|
Geode Capital Management
Boston,
Massachusetts
|
$194M
|
+$984K
|
+15,815
|
+0.5%
|
|
|
9
|
Bank of America
Charlotte,
North Carolina
|
$187M
|
-$7.5M
|
-120,644
|
-4%
|
|
|
10
|
|
$173M
|
–
|
–
|
–
|
|
|
11
|
Polar Capital Holdings
London,
United Kingdom
|
$154M
|
-$22.4M
|
-360,318
|
-13%
|
|
|
12
|
|
$151M
|
+$45.8M
|
+736,956
|
+45%
|
|
|
13
|
T. Rowe Price Associates
Baltimore,
Maryland
|
$123M
|
-$27.2M
|
-436,729
|
-18%
|
|
|
14
|
Woodline Partners
San Francisco,
California
|
$105M
|
+$43.7K
|
+703
|
+0%
|
|
|
15
|
|
$89.8M
|
-$8.09M
|
-130,060
|
-8%
|
|
|
16
|
Integral Health Asset Management
New York
|
$89M
|
–
|
–
|
–
|
|
|
17
|
Charles Schwab
San Francisco,
California
|
$87.9M
|
+$594K
|
+9,554
|
+0.7%
|
|
|
18
|
Northern Trust
Chicago,
Illinois
|
$87.7M
|
-$1.62M
|
-26,045
|
-2%
|
|
|
19
|
|
$80.4M
|
-$15.9M
|
-255,885
|
-17%
|
|
|
20
|
Capital International Investors
Los Angeles,
California
|
$74.9M
|
–
|
–
|
–
|
|
|
21
|
Citadel Advisors
Miami,
Florida
|
$73.9M
|
-$13.9M
|
-223,128
|
-16%
|
|
|
22
|
UBS Group
Zurich,
Switzerland
|
$71.9M
|
-$41.8M
|
-671,795
|
-37%
|
|
|
23
|
Armistice Capital
New York
|
$63.1M
|
-$12.7M
|
-204,102
|
-17%
|
|
|
24
|
Royalty Pharma Sub-Manager
New York
|
$62.3M
|
+$61M
|
+980,392
|
New
|
|
|
25
|
Principal Financial Group
Des Moines,
Iowa
|
$62.1M
|
-$12.3M
|
-197,556
|
-17%
|
|
